Furthermore, the observed NR2F6 upregulation in biopsies of patients with defined cancer entities [39,45,47,51,52,53,54,55,56,57,59] (Figure 1 and Table 1) might thus implicate an upregulation also of lymphatic NR2F6. This evidence concerns the gene NR2F6 and cancer.